International Journal of Antimicrobial Agents
Volume 36, Issue 1 , Pages 14-18 , July 2010

‘Safe’ photoantimicrobials for skin and soft-tissue infections

Received 7 December 2009 ,Accepted 3 March 2010.

References 

  1. Browning CH, Gulbransen R, Kennaway EL, Thornton LHD. Flavine and brilliant green, powerful antiseptics with low toxicity to the tissues: their use in the treatment of infected wounds. Br Med J. 1917;i:73–78
  2. Browning CH, Gulbransen R, Thornton LHD. The antiseptic properties of acriflavine and proflavine, and brilliant green. Br Med J. 1917;ii:70–75
  3. Assinder EW. Acriflavine as a urinary antiseptic. Lancet. 1936;i:304–305
  4. Creagh TA, Gleeson M, Travis D, Grainger R, McDermott TED, Butler MR. Is there a role for in vivo methylene blue staining in the prediction of bladder tumour recurrence?. Br J Urol. 1995;75:477–479
  5. Meissner PE, Mandi G, Witte S, Coulibaly B, Mansmann U, Rengelshausen J, et al. Safety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso. Malaria J. 2005;4:45
  6. Saji M, Taguchi S, Uchiyama K, Osono E, Hayama N, Ohkuni H. Efficacy of gentian-violet in the eradication of methicillin-resistant Staphylococcus aureus from skin lesions. J Hosp Infect. 1995;31:225–228
  7. Raab OZ. Uber die wirking fluoreszierender stoffe auf infusorien. Z Biol. 1900;39:524–546
  8. Wainwright M, Phoenix DA, Laycock SL, Wareing DRA, Wright PA. Photobactericidal activity of phenothiazinium dyes against methicillin-resistant strains of Staphylococcus aureus. FEMS Microbiol Lett. 1998;160:177–181
  9. Wainwright M, Phoenix DA, Gaskell M, Marshall B. Photobactericidal activity of methylene blue derivatives against vancomycin-resistant Enterococcus spp.. J Antimicrob Chemother. 1999;44:823–825
  10. Menezes S, Capella MAM, Caldas LR. Photodynamic action of methylene blue: repair and mutation in Escherichia coli. J Photochem Photobiol B. 1990;5:505–517
  11. Ergaieg K, Seux R. A comparative study of the photoinactivation of bacteria by meso-substituted cationic porphyrin, rose Bengal and methylene blue. Desalination. 2009;246:353–362
  12. Singh H, Vadasz JA. Singlet oxygen quenchers and the photodynamic inactivation of E. coli ribosomes by methylene blue. Biochem Biophys Res Comm. 1977;76:391–397
  13. Tuite EM, Kelly JM. New trends in photobiology: photochemical interactions of methylene blue and analogues with DNA and other biological substrates. J Photochem Photobiol B. 1993;21:103–124
  14. Wainwright M, Crossley KB. Methylene blue—a therapeutic dye for all seasons?. J Chemother. 2002;14:431–443
  15. Unno N, Suzuki M, Yamamoto N, Inuzuka K, Sagara D, Nishiyama M, et al. Indocyanine green fluorescence angiography for intraoperative assessment of blood flow: a feasibility study. Eur J Vasc Endovasc Surg. 2008;35:205–207
  16. Wainwright M. Photosensitisers in biomedicine. Chichester, UK: John Wiley & Sons Ltd.; 2009;p. 237
  17. Brown SB, Brown EA, Walker I. The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol. 2004;5:497–508
  18. Kirsch AJ, Miller MI, Hensle TW, Chang DT, Shabsigh R, Olsson CA, et al. Laser tissue soldering in urinary tract reconstruction: first human experience. Urology. 1995;46:261–266
  19. Demidova TN, Hamblin MR. Effect of cell–photosensitizer binding and cell density on microbial photoinactivation. Antimicrob Agents Chemother. 2005;49:2329–2335
  20. Günther WHH, Searle R, Sieber F. Structure–activity relationships in the antiviral and antileukemic photoproperties of merocyanine dyes. Semin Hematol. 1992;29:88–94
  21. Wood S, Metcalf D, Devine D, Robinson R. Erythrosine is a potential photosensitizer for the photodynamic therapy of oral plaque biofilms. J Antimicrob Chemother. 2006;57:680–684
  22. Omar GS, Wilson M, Nair SP. Lethal photosensitization of wound-associated microbes using indocyanine green and near-infrared light. BMC Microbiol. 2008;8:111
  23. Matula TI, Downie RH. Genetic toxicity of erythrosine in yeast. Mutat Res. 1984;138:153–156
  24. Tardivo JP, Del Giglio A, de Oliveira CS, Gabrielli DS, Junqueira HC, Tada DB, et al. Methylene blue in photodynamic therapy: from basic mechanisms to clinical applications. Photodiagnosis Photodyn Ther. 2005;2:175–191
  25. Teichert MC, Jones JW, Usacheva MN, Biel MA. Treatment of oral candidiasis with methylene blue-mediated photodynamic therapy in an immunodeficient murine model. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;93:155–160
  26. National Audit Office . Reducing healthcare-associated infections in hospitals in England. London, UK: Stationery Office; 2009;
  27. Schultz EW, Krueger AP. Inactivation of Staphylococcus bacteriophage by methylene blue. Proc Soc Exp Biol Med. 1928;26:100–101
  28. T’ung T. In vitro photodynamic action of methylene blue on Trypanosoma brucei. Proc Soc Exp Biol Med. 1938;38:29–31
  29. Mohr H, Lambrecht B, Selz A. Photodynamic virus inactivation of blood components. Immunol Invest. 1995;24:73–85
  30. Wallis C, Melnick JL. Photodynamic inactivation of poliovirus. Virology. 1963;21:332–341
  31. Felber TD, Smith EB, Knox JM, Wallis C, Melnick JL. Photodynamic inactivation of herpes simplex: report of a clinical trial. JAMA. 1973;223:289–292
  32. Mohr H, Lambrecht B, Knuever-Hopf J. Virus inactivated single-donor fresh plasma preparations. Infusionsther Transfusionsmed. 1992;19:79–83
  33. Szpakowska M, Reiss J, Graczyk A, Szmigielski S, Lasocki K, Grzybowski J. Susceptibility of Pseudomonas aeruginosa to a photodynamic effect of the arginine hematoporphyrin derivative. Int J Antimicrob Agents. 1997;8:23–27
  34. Demidova TN, Hamblin MR. Photodynamic inactivation of Bacillus spores, mediated by phenothiazinium dyes. Appl Environ Microbiol. 2005;71:6918–6925
  35. Dai T, Tegos GP, Lu Z, Huang L, Zhiyentayev T, Franklin MJ, et al. Photodynamic therapy for Acinetobacter baumannii burn infections in mice. Antimicrob Agents Chemother. 2009;53:3929–3934
  36. Lavergne S, Darmon M, Levy V, Azoulay E. Methemoglobinemia and acute hemolysis after tetracaine lozenge use. J Crit Care. 2006;21:112–114
  37. Thevarajah S, Huston TL, Simmons RM. A comparison of the adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer. Am J Surg. 2005;189:236–239
  38. Wainwright M, Phoenix DA, Marland J, Wareing DRA, Bolton FJ. A study of photobactericidal activity in the phenothiazinium series. FEMS Immunol Med Microbiol. 1997;19:75–80
  39. Wilson M, Dobson J, Harvey W. Sensitization of oral bacteria to killing by low-power laser radiation. Curr Microbiol. 1992;25:77–81
  40. Wilson M, Mia N. Sensitisation of Candida albicans to killing by low-power laser light. J Oral Pathol Med. 1993;22:354–357
  41. Rasooly A, Weisz A. In vitro antibacterial activities of phloxine B and other halogenated fluoresceins against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2002;46:3650–3653

PII: S0924-8579(10)00117-2

doi: 10.1016/j.ijantimicag.2010.03.002

International Journal of Antimicrobial Agents
Volume 36, Issue 1 , Pages 14-18 , July 2010

Article Tools

* Image Usage & Resolution